11.89
+0.04(+0.34%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
3362
First IPO Date
May 28, 2015
| Name | Title | Pay | Year Born |
| Mr. Tengxiang Long | Director of R&D - Reagents | 0 | 1982 |
| Ms. Shan Yin | Chief Financial Officer & Director | 0 | 1981 |
| Mr. Shengguo Xu | Director of Marketing | 0 | 1980 |
| Ping You | Accounting Supervisor | 0 | N/A |
| Ms. Wei Shi | Secretary & Director of Strategic Investment | 0 | 1975 |
| Mr. Weijia Wang | Director of R&D - Instrumentation | 0 | 1984 |
| Ms. Ping Yu | Administrative Director & Manager of Human Resource Department | 0 | 1981 |
| Mr. Wu Mingjian | GM & Director | 0 | 1977 |
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It also provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. The company was incorporated in 1994 and is based in Chengdu, China.